COVID-19: Israel approves AstraZeneca's Evusheld vaccine for immunocompromised
Evusheld has proven to be 83% effective in preventing serious illness and death from COVID-19.
A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021(photo credit: DADO RUVIC/REUTERS)Updated: 
